Screening Type Two Diabetes Complications
Various complications arise from type 2 diabetes. These complications are both short term and long term and people with this condition are advised to go for regular screening, preferably every year so that immediate measures can be taken on any complication noticed (Hajos et al., 2013). Therefore, testing must be performed to patients for the outlined complications on a frequent basis.
Screening for nerve damage and circulation
Also known as foot examination and screening for circulation together with nerve damage is done by examining the patient’s feet. It involves test for senses such as touch, feelings and blood circulation on the feet (Simmons et al., 2012).
Screening for cholesterol
The screening process for cholesterol takes some time. Similar to the first two, the patient should take the test every year. A small portion of blood is obtained from blood vein around the region of the elbow of the arm then transferred to the laboratory for test. Additionally, the lab test is quite lengthy, and it takes some days before the result is ready (Poirier et al., 2011).
Blood pressure screening
Blood pressure is obviously one of the conditions closely associated with type 2 diabetes. A regular blood pressure test is, therefore, indispensible for patients with this condition. The test is done using a fabric sleeve that also helps to check the patient’s pulse rate and the process take few minutes (Lyssenko & Laakso, 2013).
Screening for kidney disease
The test is also known as nephropathy and is one of the simplest to perform since it is a test for protein. The patient is asked to provide urine that is then tested for the presence of protein (Srinivasan et al., 2005).
Screening for type 2 diabetes complications should, therefore, be done as explained above for better health care to people with the condition.
Hajos, T. R. S., Pouwer, F., Skovlund, S. E., Den Oudsten, B. L., Geelhoed‐Duijvestijn, P. H. L. M., Tack, C. J., & Snoek, F. J. (2013). Psychometric and screening properties of the WHO‐5 well‐being index in adult outpatients with Type 1 or Type 2 diabetes mellitus. Diabetic Medicine, 30(2), e63-e69.
Lyssenko, V., & Laakso, M. (2013). Genetic Screening for the Risk of Type 2 Diabetes Worthless or valuable?. Diabetes care, 36(Supplement 2), S120-S126.
Poirier, P., Bogaty, P., Garneau, C., Marois, L., & Dumesnil, J. G. (2001). Diastolic Dysfunction in Normotensive Men with Well-Controlled Type 2 Diabetes Importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes care, 24(1), 5-10.
Simmons, R. K., Echouffo-Tcheugui, J. B., Sharp, S. J., Sargeant, L. A., Williams, K. M., Prevost, A. T., … & Griffin, S. J. (2012). Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. The Lancet, 380(9855), 1741-1748.
Srinivasan, K., Viswanad, B., Asrat, L., Kaul, C. L., & Ramarao, P. (2005). Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacological research, 52(4), 313-320.